Cellect Biotechnology Ltd Forecast and Stock Analysis
Technical APOP stock analysis for February 15, 2019.
Cellect Biotechnology Ltd fell by -2.86% in the last day from $1.05 to $1.02 and has now fallen 3 days in a row. The price has fallen in 8 of the last 10 days and is down by -54.67% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -159 722 shares and in total 177 938 shares bought and sold for approximately $181 497.00.
Close price at the end of the last trading day (Friday, 15th Feb 2019) of the APOP stock was $1.02. This is 2.86% less than the trading day before Thursday, 14th Feb 2019.
During day the stock fluctuated 8.00% from a day low at $1.00 to a day high of $1.08.
30 day high of the APOP stock price was $3.83 and low was $1.00.
90 day high was $4.35 and low was $1.00.
52 week high for the Cellect Biotechnology Ltd - $7.85 and low - $1.00.
Cellect Biotechnology Ltd lies in the lower of a very wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $0.93 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -51.34% during the next 3 months and, with 90% probability hold a price between $0.45 and $1.01 at the end of this period.
There are few to none technical positive signals at the moment. Cellect Biotechnology Ltd holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $1.26 and $2.32. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday February 07, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Relative Strength Index (RSI)
The stock currently holds a RSI14 at 25 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.
Support & Resistance
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.08 between high and low, or 8.00%. For the last week the stock has had a daily average volatility of 11.22%.
Cellect Biotechnology Ltd is oversold on RSI14 (25). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Sell Candidate
Cellect Biotechnology Ltd holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.